FDA Approves Tecnis Symfony IOL for Cataract Surgery Patients
August 8, 2016
On July 15, 2016, the FDA announced that it had approved the Tecnis Symfony intraocular lens (IOL) – the first IOL to provide cataract patients with an extended depth-of-focus, which helps improve their sharpness of vision at near, intermediate and far distances. In cataract surgery, the clouded natural lens is removed and replaced with an IOL.
As the FDA explained, traditional monofocal IOLs have been limited to improving distance vision. The Tecnis Symfony IOL improves visual acuity at close, intermediate and far ranges and, therefore, may reduce the need for patients to wear contact lenses or glasses after cataract surgery.
Click here to read the FDA’s full announcement.
Click here to learn more about the Tecnis Symfony IOL.
Comments
Jump down to form below to submit your own comments
